Evaluation of a Noninvasive Fetal RHD Genotyping Test (IRIS)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years to 64 Years (Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Pregnant subjects who are RhD negative and between 10 and 28 weeks gestation.
Subject is 18-64 years of age
Subject is female
Subject is pregnant
Subject is RhD negative
Subject is between 10 and 28 weeks gestation
Subject provides informed consent
Subject agrees to provide neonatal RHD and sex outcome